{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T10:14:56Z","timestamp":1777630496001,"version":"3.51.4"},"reference-count":73,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,2,11]],"date-time":"2020-02-11T00:00:00Z","timestamp":1581379200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Osteoporosis and Sarcopenia"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.afos.2020.02.002","type":"journal-article","created":{"date-parts":[[2020,3,3]],"date-time":"2020-03-03T08:10:01Z","timestamp":1583223001000},"page":"1-7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Management of glucocorticoid-related osteoporotic vertebral fracture"],"prefix":"10.1016","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4343-5867","authenticated-orcid":false,"given":"Stella Pui Yan","family":"Wong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3696-1228","authenticated-orcid":false,"given":"Chi Chiu","family":"Mok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.afos.2020.02.002_bib1","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1097\/BOR.0000000000000608","article-title":"Glucocorticoid-induced osteoporosis update","volume":"31","author":"Adami","year":"2019","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.afos.2020.02.002_bib2","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1007\/s00198-019-04906-x","article-title":"Glucocorticoid-induced osteoporosis: 2019 concise clinical review","volume":"30","author":"Adami","year":"2019","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.afos.2020.02.002_bib3","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1007\/s00198-011-1627-9","article-title":"Ethnic difference of clinical vertebral fracture risk","volume":"23","author":"Bow","year":"2012","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.afos.2020.02.002_bib4","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/S0140-6736(02)08657-9","article-title":"Epidemiology and outcomes of osteoporotic fractures","volume":"359","author":"Cummings","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.afos.2020.02.002_bib5","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s00774-003-0467-x","article-title":"Epidemiology and diagnostic approaches to vertebral fractures in Asia","volume":"22","author":"Kung","year":"2004","journal-title":"J\u00a0Bone Miner Metabol"},{"key":"10.1016\/j.afos.2020.02.002_bib6","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1532-5415.2000.tb02641.x","article-title":"Prevalent vertebral deformities predict mortality and hospitalization in older women with low bone mass. Fracture Intervention Trial Research Group","volume":"48","author":"Ensrud","year":"2000","journal-title":"J\u00a0Am Geriatr Soc"},{"key":"10.1016\/j.afos.2020.02.002_bib7","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1001\/archinte.159.11.1215","article-title":"Vertebral fractures and mortality in older women: a prospective study. Study of Osteoporotic Fractures Research Group","volume":"159","author":"Kado","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.afos.2020.02.002_bib8","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00198-002-1316-9","volume":"14","author":"Hasserius","year":"2003","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.afos.2020.02.002_bib9","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1007\/s00330-012-2622-z","article-title":"Review of radiological scoring methods of osteoporotic vertebral fractures for clinical and research settings","volume":"23","author":"Oei","year":"2013","journal-title":"Eur Radiol"},{"key":"10.1016\/j.afos.2020.02.002_bib10","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jocd.2015.08.004","article-title":"Epidemiology of vertebral fractures","volume":"19","author":"Schousboe","year":"2016","journal-title":"J\u00a0Clin Densitom"},{"key":"10.1016\/j.afos.2020.02.002_bib11","first-page":"1017","article-title":"Epidemiology and management of osteoporosis in the People\u2019s Republic of China: current perspectives","volume":"10","author":"Lin","year":"2015","journal-title":"Clin Interv Aging"},{"key":"10.1016\/j.afos.2020.02.002_bib12","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1359\/jbmr.2000.15.10.2019","article-title":"Vertebral fractures in Beijing, China: the Beijing osteoporosis project","volume":"15","author":"Ling","year":"2000","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.afos.2020.02.002_bib13","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/s00198-012-2040-8","article-title":"Prevalence and risk factors of radiographic vertebral fractures in elderly Chinese men and women: results of Mr. OS (Hong Kong) and Ms. OS (Hong Kong) studies","volume":"24","author":"Kwok","year":"2013","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.afos.2020.02.002_bib14","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s002239900118","article-title":"Prevalence of vertebral fractures in Chinese men and women in urban Taiwanese communities","volume":"59","author":"Tsai","year":"1996","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.afos.2020.02.002_bib15","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s001980200112","article-title":"Defining incident vertebral deformities in population studies: a comparison of morphometric criteria","volume":"13","author":"Lunt","year":"2002","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.afos.2020.02.002_bib16","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/jbmr.5650080915","article-title":"Vertebral fracture assessment using a semiquantitative technique","volume":"8","author":"Genant","year":"1993","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.afos.2020.02.002_bib17","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1359\/jbmr.071032","article-title":"Algorithm-based qualitative and semiquantitative identification of prevalent vertebral fracture: agreement between different readers, imaging modalities, and diagnostic approaches","volume":"23","author":"Ferrar","year":"2008","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.afos.2020.02.002_bib18","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1007\/s00198-004-1626-1","article-title":"Comparison of methods for the visual identification of prevalent vertebral fracture in osteoporosis","volume":"15","author":"Jiang","year":"2004","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.afos.2020.02.002_bib19","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s00198-008-0657-4","article-title":"The prevalence of radiographic vertebral fractures in Latin American countries: the Latin American Vertebral Osteoporosis Study (LAVOS)","volume":"20","author":"Clark","year":"2009","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.afos.2020.02.002_bib20","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1093\/oxfordjournals.aje.a115204","article-title":"Epidemiology of vertebral fractures in women","volume":"129","author":"Melton","year":"1989","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.afos.2020.02.002_bib21","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/BF01623271","article-title":"Prevalence and incidence of vertebral deformities","volume":"3","author":"Melton","year":"1993","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.afos.2020.02.002_bib22","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1359\/jbmr.080411","article-title":"Prevalent vertebral fractures in black women and white women","volume":"23","author":"Cauley","year":"2008","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.afos.2020.02.002_bib23","doi-asserted-by":"crossref","first-page":"817","DOI":"10.2169\/internalmedicine.50.4443","article-title":"Age, initial dose and dose increase are independent risk factors for symptomatic vertebral fractures in glucocorticoid-treated male patients","volume":"50","author":"Sugiyama","year":"2011","journal-title":"Intern Med"},{"key":"10.1016\/j.afos.2020.02.002_bib24","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1007\/s00198-016-3646-z","article-title":"Glucocorticoid exposure and fracture risk in patients with new-onset rheumatoid arthritis","volume":"27","author":"Balasubramanian","year":"2016","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.afos.2020.02.002_bib25","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s001980200108","article-title":"The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis","volume":"13","author":"van Staa","year":"2002","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.afos.2020.02.002_bib26","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1002\/acr.22751","article-title":"Burden of comorbidity in systemic lupus erythematosus in the UK, 1999-2012","volume":"68","author":"Rees","year":"2016","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.afos.2020.02.002_bib27","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1002\/1529-0131(199905)42:5<882::AID-ANR6>3.0.CO;2-C","article-title":"Frequency of fractures in women with systemic lupus erythematosus: comparison with United States population data","volume":"42","author":"Ramsey-Goldman","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.afos.2020.02.002_bib28","doi-asserted-by":"crossref","first-page":"390","DOI":"10.3109\/03009742.2013.775331","article-title":"Frequency of and risk factors for symptomatic bone fractures in patients with systemic lupus erythematosus","volume":"42","author":"Ekblom-Kullberg","year":"2013","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.afos.2020.02.002_bib29","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1007\/s00198-013-2587-z","article-title":"Elevated risk of clinical fractures and associated risk factors in patients with systemic lupus erythematosus versus matched controls: a population-based study in the United Kingdom","volume":"25","author":"Bultink","year":"2014","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.afos.2020.02.002_bib30","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/BOR.0000000000000290","article-title":"Lupus and fractures","volume":"28","author":"Bultink","year":"2016","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.afos.2020.02.002_bib31","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1002\/jbmr.2511","article-title":"Incident vertebral fractures and risk factors in the first three years following glucocorticoid initiation among pediatric patients with rheumatic disorders","volume":"30","author":"LeBlanc","year":"2015","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.afos.2020.02.002_bib32","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1002\/acr.23279","article-title":"2017 American College of Rheumatology guideline for the prevention and treatment of glucocorticoid-induced osteoporosis","volume":"69","author":"Buckley","year":"2017","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.afos.2020.02.002_bib33","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11657-017-0324-5","article-title":"UK clinical guideline for the prevention and treatment of osteoporosis","volume":"12","author":"Compston","year":"2017","journal-title":"Arch Osteoporos"},{"key":"10.1016\/j.afos.2020.02.002_bib34","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1007\/s00198-012-1958-1","article-title":"A\u00a0framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis","volume":"23","author":"Lekamwasam","year":"2012","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.afos.2020.02.002_bib35","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s00198-010-1524-7","article-title":"Guidance for the adjustment of FRAX according to the dose of glucocorticoids","volume":"22","author":"Kanis","year":"2011","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.afos.2020.02.002_bib36","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1136\/ard.54.10.801","article-title":"Risk of vertebral fracture and relationship to bone mineral density in steroid treated rheumatoid arthritis","volume":"54","author":"Peel","year":"1995","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.afos.2020.02.002_bib37","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1007\/s00198-012-2177-5","article-title":"Alterations of bone geometry, density, microarchitecture, and biomechanical properties in systemic lupus erythematosus on long-term glucocorticoid: a case-control study using HR-pQCT","volume":"24","author":"Tang","year":"2013","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.afos.2020.02.002_bib38","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1056\/NEJM199807303390502","article-title":"Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-induced osteoporosis intervention study group","volume":"339","author":"Saag","year":"1998","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.afos.2020.02.002_bib39","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1002\/1529-0131(199911)42:11<2309::AID-ANR8>3.0.CO;2-K","article-title":"Risedronate therapy prevents corticosteroid-induced bone loss: a twelve-month, multicenter, randomized, double-blind, placebo-controlled, parallel-group study","volume":"42","author":"Cohen","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.afos.2020.02.002_bib40","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1359\/jbmr.2000.15.6.1006","article-title":"Efficacy and safety of daily risedronate in the treatment of corticosteroid-induced osteoporosis in men and women: a randomized trial. European Corticosteroid-Induced Osteoporosis Treatment Study","volume":"15","author":"Reid","year":"2000","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.afos.2020.02.002_bib41","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s002230001146","article-title":"Effects of risedronate treatment on bone density and vertebral fracture in patients on corticosteroid therapy","volume":"67","author":"Wallach","year":"2000","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.afos.2020.02.002_bib42","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/S0140-6736(09)60250-6","article-title":"Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomised controlled trial","volume":"373","author":"Reid","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.afos.2020.02.002_bib43","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1056\/NEJMoa071408","article-title":"Teriparatide or alendronate in glucocorticoid-induced osteoporosis","volume":"357","author":"Saag","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.afos.2020.02.002_bib44","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.1002\/art.24879","article-title":"Effects of teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: thirty-six-month results of a randomized, double-blind, controlled trial","volume":"60","author":"Saag","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.afos.2020.02.002_bib45","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.bone.2015.03.002","article-title":"Switching of oral bisphosphonates to denosumab in chronic glucocorticoid users: a 12-month randomized controlled trial","volume":"75","author":"Mok","year":"2015","journal-title":"Bone"},{"key":"10.1016\/j.afos.2020.02.002_bib46","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S2213-8587(18)30075-5","article-title":"Denosumab versus risedronate in glucocorticoid-induced osteoporosis: a multicentre, randomised, double-blind, active-controlled, double-dummy, non-inferiority study","volume":"6","author":"Saag","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.afos.2020.02.002_bib47","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1002\/art.40874","article-title":"Denosumab versus risedronate in glucocorticoid-induced osteoporosis: final results of a twenty-four-month randomized, double-blind, double-dummy trial","volume":"71","author":"Saag","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.afos.2020.02.002_bib48","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1210\/jc.2016-3170","article-title":"Severe rebound-associated vertebral fractures after denosumab discontinuation: 9 clinical cases report","volume":"102","author":"Lamy","year":"2017","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.afos.2020.02.002_bib49","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1002\/jbmr.3110","article-title":"Clinical features of 24 patients with rebound-associated vertebral fractures after denosumab discontinuation: systematic review and additional cases","volume":"32","author":"Anastasilakis","year":"2017","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.afos.2020.02.002_bib50","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.bone.2017.08.003","article-title":"Discontinuation of denosumab therapy for osteoporosis: a systematic review and position statement by ECTS","volume":"105","author":"Tsourdi","year":"2017","journal-title":"Bone"},{"key":"10.1016\/j.afos.2020.02.002_bib51","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1007\/s00198-017-4108-y","article-title":"Possible protective effect of switching from denosumab to zoledronic acid on vertebral fractures","volume":"28","author":"Lehmann","year":"2017","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.afos.2020.02.002_bib52","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1136\/ard.2010.143453","article-title":"Raloxifene for prevention of glucocorticoid-induced bone loss: a 12-month randomised double-blinded placebo-controlled trial","volume":"70","author":"Mok","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.afos.2020.02.002_bib53","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000008659","article-title":"Efficacy and safety of bazedoxifene in postmenopausal women with osteoporosis: a systematic review and meta-analysis","volume":"96","author":"Peng","year":"2017","journal-title":"Medicine (Baltim)"},{"key":"10.1016\/j.afos.2020.02.002_bib54","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1080\/14656566.2019.1615882","article-title":"Bazedoxifene for the treatment of osteoporosis","volume":"20","author":"Yavropoulou","year":"2019","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.afos.2020.02.002_bib55","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/j.spinee.2017.07.174","article-title":"An overview of clinical guidelines for the management of vertebral compression fracture: a systematic review","volume":"17","author":"Parreira","year":"2017","journal-title":"Spine J"},{"key":"10.1016\/j.afos.2020.02.002_bib56","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00198-011-1676-0","article-title":"Calcitonin for treating acute and chronic pain of recent and remote osteoporotic vertebral compression fractures: a systematic review and meta-analysis","volume":"23","author":"Knopp-Sihota","year":"2012","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.afos.2020.02.002_bib57","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s00234-018-2042-0","article-title":"What is the role of vertebral augmentation for osteoporotic fractures? A review of the recent literature","volume":"60","author":"Marcia","year":"2018","journal-title":"Neuroradiology"},{"key":"10.1016\/j.afos.2020.02.002_bib58","doi-asserted-by":"crossref","first-page":"54","DOI":"10.25259\/SNI-123-2019","article-title":"A\u00a0comparison of kyphoplasty, vertebroplasty, or non-surgical treatment of traumatic\/atraumatic osteoporotic vertebral compression fractures: a short review","volume":"10","author":"Epstein","year":"2019","journal-title":"Surg Neurol Int"},{"key":"10.1016\/j.afos.2020.02.002_bib59","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/jbmr.3653","article-title":"The efficacy and safety of vertebral augmentation: a second ASBMR task force report","volume":"34","author":"Ebeling","year":"2019","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.afos.2020.02.002_bib60","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1056\/NEJMoa0900429","article-title":"A\u00a0randomized trial of vertebroplasty for painful osteoporotic vertebral fractures","volume":"361","author":"Buchbinder","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.afos.2020.02.002_bib61","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1056\/NEJMoa0900563","article-title":"A\u00a0randomized trial of vertebroplasty for osteoporotic spinal fractures","volume":"361","author":"Kallmes","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.afos.2020.02.002_bib62","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1016\/S0140-6736(16)31341-1","article-title":"Safety and efficacy of vertebroplasty for acute painful osteoporotic fractures (VAPOUR): a multicentre, randomised, double-blind, placebo-controlled trial","volume":"388","author":"Clark","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.afos.2020.02.002_bib63","doi-asserted-by":"crossref","first-page":"k1551","DOI":"10.1136\/bmj.k1551","article-title":"Vertebroplasty versus sham procedure for painful acute osteoporotic vertebral compression fractures (VERTOS IV): randomised sham controlled clinical trial","volume":"361","author":"Firanescu","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.afos.2020.02.002_bib64","article-title":"Percutaneous vertebroplasty for osteoporotic vertebral compression fracture","volume":"4","author":"Buchbinder","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.afos.2020.02.002_bib65","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/S0140-6736(09)60010-6","article-title":"Efficacy and safety of balloon kyphoplasty compared with non-surgical care for vertebral compression fracture (FREE): a randomised controlled trial","volume":"373","author":"Wardlaw","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.afos.2020.02.002_bib66","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.jacr.2014.04.011","article-title":"ACR appropriateness criteria management of vertebral compression fractures","volume":"11","author":"McConnell","year":"2014","journal-title":"J\u00a0Am Coll Radiol"},{"key":"10.1016\/j.afos.2020.02.002_bib67","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.2106\/JBJS.9320ebo","article-title":"American Academy of Orthopaedic Surgeons clinical practice guideline on: the treatment of osteoporotic spinal compression fractures","volume":"93","author":"Esses","year":"2011","journal-title":"J\u00a0Bone Joint Surg Am"},{"key":"10.1016\/j.afos.2020.02.002_bib68","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jvir.2013.10.001","volume":"25","author":"Barr","year":"2014","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.afos.2020.02.002_bib69","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1359\/jbmr.040207","article-title":"Multiple adjacent vertebral fractures after kyphoplasty in a patient with steroid-induced osteoporosis","volume":"19","author":"Donovan","year":"2004","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.afos.2020.02.002_bib70","first-page":"1938","article-title":"Symptomatic refractures after vertebroplasty in patients with steroid-induced osteoporosis","volume":"27","author":"Syed","year":"2006","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.afos.2020.02.002_bib71","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.3174\/ajnr.A2148","article-title":"Percutaneous vertebroplasty is not a risk factor for new osteoporotic compression fractures: results from VERTOS II","volume":"31","author":"Klazen","year":"2010","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.afos.2020.02.002_bib72","doi-asserted-by":"crossref","first-page":"797","DOI":"10.3348\/kjr.2014.15.6.797","article-title":"Percutaneous vertebroplasty of the entire thoracic and lumbar vertebrae for vertebral compression fractures related to chronic glucocorticosteriod use: case report and review of literature","volume":"15","author":"Tian","year":"2014","journal-title":"Korean J Radiol"},{"key":"10.1016\/j.afos.2020.02.002_bib73","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.spinee.2013.06.032","article-title":"Vertebroplasty and kyphoplasty: national outcomes and trends in utilization from 2005 through 2010","volume":"15","author":"Goz","year":"2015","journal-title":"Spine J"}],"container-title":["Osteoporosis and Sarcopenia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405525520300169?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405525520300169?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T07:34:22Z","timestamp":1762500862000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405525520300169"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":73,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S2405525520300169"],"URL":"https:\/\/doi.org\/10.1016\/j.afos.2020.02.002","relation":{},"ISSN":["2405-5255"],"issn-type":[{"value":"2405-5255","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of glucocorticoid-related osteoporotic vertebral fracture","name":"articletitle","label":"Article Title"},{"value":"Osteoporosis and Sarcopenia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.afos.2020.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Korean Society of Osteoporosis. Publishing services by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}